ArticleCardiovascular diabetology2025
Association of triglyceride-glucose-related indices with all-cause and cause-specific mortality in individuals with prediabetesss.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- The association of triglyceride-glucose index with cancer incidence and mortality: a systematic review and meta-analysis of cohort studies.Frontiers in endocrinology · 2025Pooled it
- The obesity paradox effect of triglyceride-glucose-body mass index (TyG-BMI) on all-cause mortality in patients with malignant tumors: a machine learning-driven cohort study.Translational cancer research · 2026Article
- Associations of cumulative exposure and dynamic trajectories of cholesterol-HDL-glucose (CHG) index with cardiovascular disease in middle-aged and older Chinese adults: a longitudinal analysis.Cardiovascular diabetology · 2026Article
- Prognostic stratification of cardiovascular risk and cardiac remodeling in prediabetes: a multimodal analysis comparing ADA and WHO/IEC diagnostic criteria.Cardiovascular diabetology · 2026Observational
- Cholesterol-high-density lipoprotein-glucose index versus triglyceride-glucose-derived indices for predicting 10-year cardiovascular mortality in the MASHAD cohort.Scientific reports · 2026Article
- Simplicity meets accuracy: TyG-Waist as a practical alternative to CVAI for type 2 diabetes prediction in high-risk Chinese adults.BMC endocrine disorders · 2026Article
- PODiaCarD: a prototype of a digital twin platform for the management of pediatric obesity and related cardiometabolic complications.European journal of pediatrics · 2026Article
- Cumulative of c-reactive protein-triglyceride glucose index exposure and risk of diabetes in middle-aged and older Chinese adults: findings from a national longitudinal cohort.Diabetology & metabolic syndrome · 2025Article
- Comprehensive evaluation of the prevalent insulin resistance indices for pan-cancer incidence and mortality prediction.Tropical medicine and health · 2025Article
- Combination of triglyceride-glucose index and waist-to-height ratio as a predictor of all-cause and cardiovascular mortality in adults with diabetes or prediabetes: a nationwide prospective cohort study.Cardiovascular diagnosis and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe triglyceride-glucose (TyG) index has been linked to the occurrence of prediabetes, but there is limited evidence regarding its association with mortality in individuals with prediabetes. Thus, this study aimed to explore the association between TyG-related indices and all-cause and cause-specific mortality in individuals with prediabetes.
methodBased on NHANES data from 1999 to 2018, the TyG index, TyG-waist circumference (TyG-WC), and TyG-waist-to-height ratio (TyG-WHtR) were calculated. Mortality data including all-cause mortality, cardiovascular disease (CVD) mortality, and cancer mortality were determined as of December 31, 2019. Kaplan-Meier curves, Cox regression analysis, and restricted cubic splines (RCS) were used to assess associations of TyG-related indices with all-cause and cause-specific mortality (CVD and cancer) in individuals with prediabetes. Subgroup and sensitivity analyses were used to confirm the robustness of the results.
resultsIn total, 9,574 participants with prediabetes were included. Kaplan-Meier curves indicated that overall survival and cancer-specific survival were associated with different quartiles of the TyG index, with quartile 1 having the lowest all-cause mortality (P = 0.042 and P = 0.008). TyG-WHtR was negatively correlated with overall survival and CVD-specific survival (P < 0.001 and P = 0.012). Multivariate Cox regression analysis showed a significant positive correlation between the TyG index and cancer mortality (Q4: HR = 1.957, 95% CI: 1.126-3.402, P = 0.017). High quartiles of TyG-WC were significantly associated with cancer mortality in participants with prediabetes (HR = 2.397, 95% CI, 1.062-5.409, P = 0.035). Similarly, higher quartiles of TyG-WHtR were positively associated with all-cause, CVD, and cancer mortality. RCS analysis showed that TyG-WC and TyG-WHtR were nonlinearly correlated with cancer mortality (P for nonlinear = 0.028 and 0.006).
conclusionElevated TyG and TyG-WC levels were significantly associated with increased cancer mortality risk, while TyG-WHtR showed stronger associations with all-cause and cause-specific mortality in individuals with prediabetes. These indices could serve as surrogate biomarkers for follow-up and clinical management of individuals with prediabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.